J Maranzano1,2, M Dadar2,3, D A Rudko2,3, D De Nigris2, C Elliott2, J S Gati4, S A Morrow5, R S Menon4,6, D L Collins2,3, D L Arnold2, S Narayanan2. 1. From the Department of Anatomy (J.M.), University of Quebec in Trois-Rivieres, Trois-Rivieres, Quebec, Canada josefina.maranzano@uqtr.ca josefina.maranzano@mail.mcgill.ca. 2. McConnell Brain Imaging Centre (J.M., M.D., D.A.R., D.D.N., C.E., D.L.C., D.L.A., S.N.), Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada. 3. Department of Biomedical Engineering (M.D., D.A.R., D.L.C.), McGill University, Montreal, Quebec, Canada. 4. Centre for Functional and Metabolic Mapping (J.S.G., R.S.M.), Robarts Research Institute, University of Western Ontario, London, Ontario, Canada. 5. Department of Clinical Neurological Sciences (S.A.M.), London Health Sciences Centre, University of Western Ontario, London, Ontario, Canada. 6. Department of Medical Biophysics (R.S.M.), University of Western Ontario, London, Ontario, Canada.
Abstract
BACKGROUND AND PURPOSE: Our aims were the following: 1) to compare multicontrast cortical lesion detection using 3T and 7T MR imaging, 2) to compare cortical lesion type frequency in relapsing-remitting and secondary-progressive MS, and 3) to assess whether detectability is related to the magnetization transfer ratio, an imaging marker sensitive to myelin content. MATERIALS AND METHODS: Multicontrast 3T and 7T MR images from 10 participants with relapsing-remitting MS and 10 with secondary-progressive MS. We used the following 3T contrast sequences: 3D-T1-weighted, quantitative T1, FLAIR, magnetization-transfer, and 2D proton-density- and T2-weighted. We used the following 7T contrast sequences: 3D-T1-weighted, quantitative T1, and 2D-T2*-weighted. RESULTS: Cortical lesion counts at 7T were the following: 720 total cortical lesions, 420 leukocortical lesions (58%), 27 intracortical lesions (4%), and 273 subpial lesions (38%). Cortical lesion counts at 3T were the following: 424 total cortical, 393 leukocortical (93%), zero intracortical, and 31 subpial (7%) lesions. Total, intracortical, and subpial 3T lesion counts were significantly lower than the 7T counts (P < .002). Leukocortical lesion counts were not significantly different between scanners. Total and leukocortical lesion counts were significantly higher in secondary-progressive MS, at 3T and 7T (P ≤ .02). Subpial lesions were significantly higher in secondary-progressive MS at 7T (P = .006). The magnetization transfer ratio values of leukocortical lesions visible on both scanners were significantly lower than the magnetization transfer ratio values of leukocortical lesions visible only at 3T. No significant difference was found in magnetization transfer ratio values between subpial lesions visible only at 7T and subpial lesions visible on both 3T and 7T. CONCLUSIONS: Detection of leukocortical lesions at 3T is comparable with that at 7T MR imaging. Imaging at 3T is less sensitive to intracortical and subpial lesions. Leukocortical lesions not visible on 7T T2*-weighted MRI may be associated with less demyelination than those that are visible. Detectability of subpial lesions does not appear to be related to the degree of demyelination.
BACKGROUND AND PURPOSE: Our aims were the following: 1) to compare multicontrast cortical lesion detection using 3T and 7T MR imaging, 2) to compare cortical lesion type frequency in relapsing-remitting and secondary-progressive MS, and 3) to assess whether detectability is related to the magnetization transfer ratio, an imaging marker sensitive to myelin content. MATERIALS AND METHODS: Multicontrast 3T and 7T MR images from 10 participants with relapsing-remitting MS and 10 with secondary-progressive MS. We used the following 3T contrast sequences: 3D-T1-weighted, quantitative T1, FLAIR, magnetization-transfer, and 2D proton-density- and T2-weighted. We used the following 7T contrast sequences: 3D-T1-weighted, quantitative T1, and 2D-T2*-weighted. RESULTS: Cortical lesion counts at 7T were the following: 720 total cortical lesions, 420 leukocortical lesions (58%), 27 intracortical lesions (4%), and 273 subpial lesions (38%). Cortical lesion counts at 3T were the following: 424 total cortical, 393 leukocortical (93%), zero intracortical, and 31 subpial (7%) lesions. Total, intracortical, and subpial 3T lesion counts were significantly lower than the 7T counts (P < .002). Leukocortical lesion counts were not significantly different between scanners. Total and leukocortical lesion counts were significantly higher in secondary-progressive MS, at 3T and 7T (P ≤ .02). Subpial lesions were significantly higher in secondary-progressive MS at 7T (P = .006). The magnetization transfer ratio values of leukocortical lesions visible on both scanners were significantly lower than the magnetization transfer ratio values of leukocortical lesions visible only at 3T. No significant difference was found in magnetization transfer ratio values between subpial lesions visible only at 7T and subpial lesions visible on both 3T and 7T. CONCLUSIONS: Detection of leukocortical lesions at 3T is comparable with that at 7T MR imaging. Imaging at 3T is less sensitive to intracortical and subpial lesions. Leukocortical lesions not visible on 7T T2*-weighted MRI may be associated with less demyelination than those that are visible. Detectability of subpial lesions does not appear to be related to the degree of demyelination.
Authors: MariaPia Sormani; Maria L Stromillo; Marco Battaglini; Alessio Signori; Nicola De Stefano Journal: Mult Scler Date: 2011-07-14 Impact factor: 6.312
Authors: A Scott Nielsen; R Philip Kinkel; Emanuele Tinelli; Thomas Benner; Julien Cohen-Adad; Caterina Mainero Journal: J Magn Reson Imaging Date: 2011-11-01 Impact factor: 4.813
Authors: Mert R Sabuncu; B T Thomas Yeo; Koen Van Leemput; Bruce Fischl; Polina Golland Journal: IEEE Trans Med Imaging Date: 2010-06-17 Impact factor: 10.048
Authors: Iris D Kilsdonk; Laura E Jonkman; Roel Klaver; Susanne J van Veluw; Jaco J M Zwanenburg; Joost P A Kuijer; Petra J W Pouwels; Jos W R Twisk; Mike P Wattjes; Peter R Luijten; Frederik Barkhof; Jeroen J G Geurts Journal: Brain Date: 2016-03-08 Impact factor: 13.501
Authors: Brian J Burkett; Andrew J Fagan; Joel P Felmlee; David F Black; John I Lane; John D Port; Charlotte H Rydberg; Kirk M Welker Journal: Neuroradiology Date: 2021-01-02 Impact factor: 2.804
Authors: Constantina A Treaba; Elena Herranz; Valeria T Barletta; Ambica Mehndiratta; Russell Ouellette; Jacob A Sloane; Eric C Klawiter; Revere P Kinkel; Caterina Mainero Journal: J Neurol Date: 2021-02-01 Impact factor: 4.849
Authors: Erin S Beck; Josefina Maranzano; Nicholas J Luciano; Prasanna Parvathaneni; Stefano Filippini; Mark Morrison; Daniel J Suto; Tianxia Wu; Peter van Gelderen; Jacco A de Zwart; Samson Antel; Dumitru Fetco; Joan Ohayon; Frances Andrada; Yair Mina; Chevaz Thomas; Steve Jacobson; Jeff Duyn; Irene Cortese; Sridar Narayanan; Govind Nair; Pascal Sati; Daniel S Reich Journal: Mult Scler Date: 2022-02-10 Impact factor: 5.855
Authors: Constantina A Treaba; Allegra Conti; Eric C Klawiter; Valeria T Barletta; Elena Herranz; Ambica Mehndiratta; Andrew W Russo; Jacob A Sloane; Revere P Kinkel; Nicola Toschi; Caterina Mainero Journal: Brain Commun Date: 2021-06-24